Delivery Order SPE2DB22D3501-SPE2DB25FVJ48

Award Date 4/21/25
Potential Completion Date 4/22/25
Potential Value $18K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,061.38, is a delivery order for Sandostatin LAR Depot 20 mg kits. The contract has a final completion date of March 28, 2025 and utilizes a firm fixed price pricing structure. The contract is not designated with a set-aside, indicating open competition. AmerisourceBergen holds a significant...
This delivery order award, valued at $27,818.18, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Sandostatin LAR Depot 30 mg Kits. The contract has an ultimate completion date of September 13, 2024. AmerisourceBergen, as a major pharmaceutical distributor, holds multiple indefinite delivery contracts (IDCs) with DLA and other federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical for a wide range of medical commodities....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,336.65 firm fixed-price delivery order contract is for the provision of Sandostatin LAR Depot 20 mg kits, a specialty medication. The contract has an ultimate completion date of November 3, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $36,030.70 firm fixed-price delivery order is for Sandostatin LAR Depot 30 mg kits, a specialty medication. The contract has an ultimate completion date of January 5, 2024. This award is part of a broader $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $12,217.87 firm fixed-price delivery order is for the pharmaceutical product Sandostatin LAR Depot 20 mg kits, with an ultimate completion date of December 30, 2024. Amerisourcebergen, a major pharmaceutical distributor and healthcare solutions provider, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $31,716.72 firm-fixed-price contract is for the supply of Sandostatin LAR Depot 20 mg kits, a specialty medication. The award has an ultimate completion date of December 21, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $8,168.76 firm fixed-price delivery order is for the supply of Sandostatin LAR Depot 30 mg kits, a specialty medication. The contract has an ultimate completion date of January 30, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,914.52 firm fixed-price delivery order contract is for the supply of Sandostatin LAR Depot 30 mg kits, a specialty medication. The contract has a period of performance through February 22, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,714.57, is for the delivery of Sandostatin LAR Depot 30 mg kits, a specialty medication. The contract is a delivery order and has a firm fixed price pricing type. It is not designated as a set-aside contract. The award has an ultimate completion date of February 7, 2025. In addition to this...
This federal contract award is for the delivery of Sandostatin LAR Depot 10 mg kits to the Defense Logistics Agency (DLA), a defense agency that supports military medical and healthcare programs. The $12,563.94 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of August 12, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FVJ48
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Sandostatin LAR Depot 30 mg kits. The $17,709.77 firm fixed-price delivery order, which is not set aside, has an ultimate completion date of April 22, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, that serves as a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including for the Defense Health Agency and U.S. Coast Guard.

Generated 7/21/25, 7:43 PM